Synthetic wound dressings-evaluation of interactions with epithelial and dermal cells in vitro

Skin Pharmacology and Physiology

Volumn 9, Issue 1, 1996, Pages 35-42

  Wollina, U ^a   Knoll B ^a   Prufer K ^a   Barth, A ^a   Muller D ^a   Huschenbeck, J ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Biocompatibility; Cell culture; Cytochrome P 450 dependent monoxygenation; Glutathione; Interleukin 6; Oxidative stress; Tissue peptide antigen; Wound dressings; Wound healing

Indexed keywords

CYTOCHROME P450; ETHOXYRESORUFIN; GLUTATHIONE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPID PEROXIDE;

ANIMAL CELL; ARTICLE; BIOCOMPATIBILITY; CELL COUNT; CELL GROWTH; CELL SECRETION; CELL STRUCTURE; CONTROLLED STUDY; EPITHELIUM CELL; FIBROBLAST; HUMAN; HUMAN CELL; HYDROCOLLOID; HYDROGEL; KERATINOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN CELL; SKIN EPITHELIUM; SKIN INJURY; WOUND DRESSING;

3T3 CELLS; ANIMALS; BANDAGES; CELL COUNT; CELL LINE; CELL SURVIVAL; EPITHELIAL CELLS; GLUTATHIONE; HUMANS; INTERLEUKINS; KERATINOCYTES; LIPID PEROXIDATION; MICE; OXIDATION-REDUCTION; PEPTIDES; SKIN; TISSUE POLYPEPTIDE ANTIGEN; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0030068841     PISSN: 16605527     EISSN: 16605535     Source Type: Journal    
DOI: 10.1159/000211388     Document Type: Article

References (27)

1. Rosdy M, Clauss LC: Cytotoxicity testing of wound dressings using normal human kératinocytes in culture. J Biomed Mater Res 1990,24: 363-377.
2. van Luyn MJA, van Wachem PB, Nieuwcnhuis P, Jonkman MF: Cytotoxicity testing of wound dressings using the methylccllulose cell culture. Biomaterials 1992; 13:267-275.
3. Körting HC, Hertinger T, Hartinger A, Kerscher M, Angerpointner T, Maibach HI: Discrimination of the irritancy potential of surfactants in vitro by two cytotoxicity assays using normal human kératinocytes. HaCaT cells and 3T3 mouse fibroblasts: Correlation with in vivo data from a soap chamber assay. J Dermatol Sei 1994;7:119-129.
4. Hoh A, Maier K: Comparative cytotoxicity tests with human kératinocytes, HaCaT cells, and skin fibroblasts to investigate skin-irritating substances; in Bernd A, Bereiter-Hahn J, Hevert F, Holzmann H (eds): Cell and Tissue Culture Models in Dermatological Research. Berlin, Springer. 1993. pp 341-347.
5. Boukamp P, Petrusscvska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE: Normal kera-tinization in a spontaneously immortalized ancuploid kératinocyte cell line. J Cell Biol 1988.106:761-771.
6. Müller D: Influence of xenobiotics on drug metabolism and its sensitive detection. Exp Pathol 1990:39:187-194.
7. Klinger W, Müller D: The influence of age on the protein concentration in scrum, liver and kidney of rats determined by various methods. Z Versuchstierkd 1974;16:146-153.
8. Yagi K: Lipid peroxides and human disease. Chcni Phys Lipids 1987;45: 337-351.
9. Ellman GL: Tissue sulfhydryl groups. Arch Biochem Biophys 1959;82:70-77.
10. Hissin PJ, Hilf R: A fluorimetric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem 1976;74:214-226.
11. Chung LY, Schmidt RJ, Andrews AM, Turner TD: A study of hydrogen peroxide generation by. and antioxidant activity of, Granuloflex™ (DuoDERM™) hvdrocolloid granules and some other hydrogel/hydrocolloid wound management materials. Br J Dermatol 1993; 129:145-153.
12. Schmidt RJ, Chung LY, Turner TD: Quantification of hydrogen peroxide generation by Granuloflex™ (DuoDERM™) hydrocolloid granules and its constituents (gelatin, sodium carboxymethylccllulose and pectin). Br J Dermatol 1993:129: 154-157.
13. Gonzales FJ: Molecular genetics of the P-450 superfamily. Pharmacotherapy 1990;45:1-138.
14. Beresford AP: CYP1A1: Friend or foe? Drug Metab Rev 1993:25:503-517.
15. Isscroff RR, Martinez DT, Ziboh VA: Alterations in fatty acid composition of murine kératinocytes with in vitro cultivation. J Invest Dermatol 1985:85:131-134.
16. Ponec M, Wccrheim A, Kempenaar J, Mommaas A, Nugteren DH: Lipid composition of cultured human kératinocytes in relation to their differentiation. J Lipid Res 1988:29: 949-961.
17. Vessey DA, Lee KH, Blacker KL: Characterization of the oxidative stress initiated in cultured human kératinocytes by treatment with peroxides. J Invest Dermatol 1992;99: 859-863.
18. Björklund V, Björklund B, Brunkener N, Grönlund H, Back M: The enigma of a human tumor marker: TPA revisited; in Cimino F, Birk-mayer GD, Klavins JV, Pimentel E, Salvatore F (eds): Tumor Markers. Berlin, dc Gruyter. 1987. pp 169-180.
19. Ochr P, Lüthgens ML, Liu Q: Tissue polypeptide antigen and specific TPA; in Sell S (ed): Serological Cancer Markers. Totowa. Humana Press, 1992, pp 193-206.
20. McKay IA, Leigh IM: Epidermal cytokines and their roles in cutaneous wound healing. Br J Dermatol 1991; 124:513-518.
21. Küpper TS: The activated kératinocyte: A model for inducible cytokine production by non-bone-marrow-derived cells in cutaneous inflammatory and immune responses. J Invest Dermatol 1990;94:146S-150S.
22. Vickery C, Ford J, Leaper D: Interleukin profile of acute wound fluid (abstract). 4th Annu Meet Eur Tissue Repair Soc. Oxford, August 1994, Kail Kwik Printing, p 83.
23. Grossman RM, Krueger J, Yourish F, Granclli-Pipcmo A, Murphy PD, May LT, Küpper TS. Sehgal P. Gottlieb AB: Interleukin-6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human kératinocytes. Proc Natl Acad Sei USA 1989;86:6367-6371.
24. Turksen K, Küpper T, Degenstein L, Williams I, Fuchs E: Interleukin 6: Insights to its function in skin by overexpression in transgenic mice. Proc Natl Acad Sei USA 1992;89: 5068-5072.
25. Ramsay AJ, Husband AJ, Ramshaw IA, Bao S, Matthaei KI, Koehler G, Kopf M: The role of interlcukin-6 in mucosal IgA antibody responses in vivo. Science 1994;264:561-563.
26. Waelti ER, Inaebnit SP, Rast HP, Hunziker T, Limat A, Braathen LR, Wiesmann U: Co-culture of human kératinocytes on post-mitotic human dermal fibroblast feeder cells: Production of large amounts of interleukin 6. J Invest Dermatol 1992; 98:805-808.
27. Jeter KF, Tintle TE: Wound dressings of the nineties: Indications and contraindications. Clin Podiatr Med Surg 1991;8:799-816.